Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annie Hawton
Colin Green

Showing results (1-10 of 143) with videos related to

Pageof 15
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 22, 2016
Health Utilities for Multiple SclerosisAnnie Hawton, Colin Green
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 23, 2017
"Naming and Framing": The Impact of Labeling on Health State Values for Multiple SclerosisColin Green, Elizabeth Goodwin, Annie Hawton
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 17, 2018
Health State Values Derived from People with Multiple Sclerosis for a Condition-Specific Preference-Based Measure: Multiple Sclerosis Impact Scale-Eight Dimensions-Patient Version (MSIS-8D-P)Elizabeth Goodwin, Colin Green, Annie Hawton
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 2, 2020
What Difference Does It Make? A Comparison of Health State Preferences Elicited From the General Population and From People With Multiple SclerosisElizabeth Goodwin, Colin Green, Annie Hawton
Applied Health Economics and Health Policy|May 3, 2013
Squinting through layers of fog: assessing the cost effectiveness of treatments for multiple sclerosisAnnie Hawton, James Shearer, Elizabeth Goodwin, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 15, 2019
Health state utility values (QALY weights) for Huntington's disease: an analysis of data from the European Huntington's Disease Network (EHDN)Annie Hawton, Colin Green, Elizabeth Goodwin, et al.
Social Science & Medicine (1982)|June 25, 2021
What drives differences in preferences for health states between patients and the public? A qualitative investigation of respondents' thought processesElizabeth Goodwin, Antoinette Davey, Colin Green, et al.
Journal of Occupational Rehabilitation|January 27, 2021
Exploring the Factors that Influence Workforce Participation for People with Multiple Sclerosis: A Discrete Choice ExperimentElizabeth Goodwin, Annie Hawton, Jennifer A Whitty, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 19, 2012
Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6DAnnie Hawton, Colin Green, Claire Telford, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 4, 2020
Measuring the cost-effectiveness of treatments for people with multiple sclerosis: Beyond quality-adjusted life-yearsAnnie Hawton, Elizabeth Goodwin, Kate Boddy, et al.
Pageof 15

Showing results (1-10 of 143) with videos related to

Sort By:
Pageof 15
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 22, 2016
Health Utilities for Multiple SclerosisAnnie Hawton, Colin Green
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 23, 2017
"Naming and Framing": The Impact of Labeling on Health State Values for Multiple SclerosisColin Green, Elizabeth Goodwin, Annie Hawton
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 17, 2018
Health State Values Derived from People with Multiple Sclerosis for a Condition-Specific Preference-Based Measure: Multiple Sclerosis Impact Scale-Eight Dimensions-Patient Version (MSIS-8D-P)Elizabeth Goodwin, Colin Green, Annie Hawton
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 2, 2020
What Difference Does It Make? A Comparison of Health State Preferences Elicited From the General Population and From People With Multiple SclerosisElizabeth Goodwin, Colin Green, Annie Hawton
Applied Health Economics and Health Policy|May 3, 2013
Squinting through layers of fog: assessing the cost effectiveness of treatments for multiple sclerosisAnnie Hawton, James Shearer, Elizabeth Goodwin, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 15, 2019
Health state utility values (QALY weights) for Huntington's disease: an analysis of data from the European Huntington's Disease Network (EHDN)Annie Hawton, Colin Green, Elizabeth Goodwin, et al.
Social Science & Medicine (1982)|June 25, 2021
What drives differences in preferences for health states between patients and the public? A qualitative investigation of respondents' thought processesElizabeth Goodwin, Antoinette Davey, Colin Green, et al.
Journal of Occupational Rehabilitation|January 27, 2021
Exploring the Factors that Influence Workforce Participation for People with Multiple Sclerosis: A Discrete Choice ExperimentElizabeth Goodwin, Annie Hawton, Jennifer A Whitty, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 19, 2012
Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6DAnnie Hawton, Colin Green, Claire Telford, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 4, 2020
Measuring the cost-effectiveness of treatments for people with multiple sclerosis: Beyond quality-adjusted life-yearsAnnie Hawton, Elizabeth Goodwin, Kate Boddy, et al.
Pageof 15